Assessment of Different Commercial Brands of Tamoxifen 10 mg TabletsMarketed in Yemen as Anti-breast Cancer
published by Damascus University
in 2009
in Pharmacy
and research's language is
العربية
Download
Abstract in English
Breast cancer is one of the most common cancers in women;
one of nine women will have breast cancer in her life time.
Tamoxifen is the trans-isomer of a triphenylethylene derivative.
The aim of this study is to evaluate the quality and the quantity of the
commercial brands of Tamoxifen 10 mg tablets which are registered and
marketed in Yemen.
References used
(Marc E. Lippman. Breast cancer, Harrison's principles of internal medicine, 16th edition, pp.516 – 523. McGraw-Hill Companies, Inc. (2005
(Supreme Board of Drugs and Medical Appliance of Yemen(2006). Hankinson Susan E. Endogenous hormones and risk of breast cancer in postmenopausal women. Breast Disease, 24(1):3-15. (2005, 2006
(World Health Organization, Quality assurance of pharmaceuticals, A compendium of guidelines and related materials vol. 2, Good manufacturing practice and inspection, pp 1,101-102. (1999